Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review

Acute respiratory distress syndrome (ARDS) is a life-threatening lung disease. It may occur during the pancytopenia phase following allogeneic hematopoietic cell transplantation (HCT). ARDS is rare following HCT. Mesenchymal stromal cells (MSCs) have strong anti-inflammatory effect and first home to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Behnam, Ringdén, Olle, Gustafsson, Britt, Castegren, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680556/
https://www.ncbi.nlm.nih.gov/pubmed/36426365
http://dx.doi.org/10.3389/fimmu.2022.963445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680556/
https://www.ncbi.nlm.nih.gov/pubmed/36426365
http://dx.doi.org/10.3389/fimmu.2022.963445

Ejemplares similares